Business

Will Psychedelic Companies Embrace Indigenous Reciprocity?

A growing number of psychedelic companies are launching programs to give back to the indigenous tribes whose traditional uses of psychedelics have been critical in shaping contemporary approaches to these medicines.

Companies Compete to Create DMT Therapies

Therapies are being developed for conditions ranging from Treatment Resistant Depression to strokes to addiction.

Lessons the Psychedelics Industry Can Learn From the Cannabis Market Bubble

Parallels between business and regulation strategies in the two sectors point to examples of what psychedelics companies should and should not do.

Turning Everyday Therapist Offices into Ketamine Clinics

A new wave of companies are assisting counselors with medicine, records, music and training.

Startup Miraculix Creates First Rapid, Mobile Test Kits For Concentrations of MDMA, LSD, and Psilocybin

Miraculix’s kit, the first to offer quantitative rapid results within 10 to 30 minutes, is a significant innovation considering many of the substances people desire to test are illegal.

Cybin Moves Forward With Market Strategies for Expansion Into Psychedelic Therapies

Cybin and Greenbrook announce partnership to roll out clinic expansion and development of psychedelic therapies.

Wake Network Successfully Completes First Legal Importation of Psilocybin Mushrooms into the U.S.

The DEA approved shipment is a milestone toward legal access to psilocybin mushrooms for U.S. clinical research and health treatments.

An Investor Looks at Drug Development Strategies of Top Psychedelic Companies

Some leading developers of psychedelic medicines are focusing on both plant-derived and synthetic molecules to create unique therapies.

How an Investor Evaluates Five Leading Psychedelic Therapy Companies

Lindsay Hoover of the JLS Fund examines the market strategies of five publicly traded companies favored by investors to bring psychedelic-assisted therapy to the mainstream.

CryptoPsychedelic Conferences Examine Links Between Psychedelics and Blockchain Technology

Cryptocurrencies such as Bitcoin have funded psychedelic research and may pave the way for financial systems that replicate more decentralized psychedelic business structures.